|
Thursday, January 14 2010 |
|
Neptune announced today financial results for the third quarter ended November 30, 2009. |
|
Wednesday, December 16 2009 |
|
Neptune announces additional preclinical research results on its Acasti Pharma Inc. drug development program. |
|
Tuesday, December 15 2009 |
|
Neptune provides guidance for the expected financial results of the fiscal 2010 third quarter ended November 30, 2009 |
|
Tuesday, November 17 2009 |
|
Neptune announced today the first preclinical research up-date on NeuroBioPharm Inc. (“NBP”) medical food development program |
|
Friday, November 13 2009 |
|
--Neptune announced today that it has filed a patent infringement lawsuit against Aker Biomarine ASA, Jedwards International, Inc., and Virgin Antarctic LLC.-- |
|
Thursday, November 05 2009 |
|
Neptune announced today the second preclinical research up-date on Acasti Pharma Inc. (“Acasti”) drug development program. |
|
Thursday, October 29 2009 |
|
--Neptune announced today the first preclinical research up-date on Acasti Pharma Inc. (“Acasti”) drug development program. -- |
|
Wednesday, October 28 2009 |
|
--Neptune is granted Method of Use Patent for Cardiovascular Disease Applications in Europe. -- |
|
Thursday, October 15 2009 |
|
--Neptune announced today operational update, financial results for the second quarter ended August 31, 2009 and announces management change-- |
|
Thursday, October 01 2009 |
|
--Production capacity recently increased by 50% to 90,000 kilograms-- |
